Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study.

Shukuya T, Yasui H, Boku N, Onozawa Y, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N.

Jpn J Clin Oncol. 2010 Dec;40(12):1135-8. doi: 10.1093/jjco/hyq117. Epub 2010 Jul 22.

PMID:
20656694
[PubMed - indexed for MEDLINE]
Free Article
2.

Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study.

Maeda S, Motoi F, Onogawa T, Morikawa T, Shigeru O, Sakata N, Takadate T, Naitoh T, Rikiyama T, Katayose Y, Egawa S, Unno M.

Int J Clin Oncol. 2011 Oct;16(5):539-45. doi: 10.1007/s10147-011-0220-8. Epub 2011 Apr 1.

PMID:
21455624
[PubMed - indexed for MEDLINE]
3.

Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancer.

Kadokura M, Iwasa S, Honma Y, Kato K, Hamaguchi T, Yamada Y, Enomoto N, Shimada Y.

Anticancer Res. 2013 Oct;33(10):4547-52.

PMID:
24123029
[PubMed - indexed for MEDLINE]
4.

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Shimoyama R, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N, Todaka A, Tomita H, Sakamoto T, Tsushima T.

Gastric Cancer. 2009;12(4):206-11. doi: 10.1007/s10120-009-0524-9. Epub 2010 Jan 5.

PMID:
20047125
[PubMed - indexed for MEDLINE]
5.

Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake.

Iwasa S, Goto M, Yasui H, Nishina T, Takahari D, Nakayama N, Taira K, Kusaba H, Fuse N, Hironaka S, Shimada Y, Nakajima TE.

Jpn J Clin Oncol. 2012 Sep;42(9):787-93. doi: 10.1093/jjco/hys111. Epub 2012 Jul 10.

PMID:
22782960
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.

Einhorn LH, Brames MJ, Juliar B, Williams SD.

J Clin Oncol. 2007 Feb 10;25(5):513-6.

PMID:
17290059
[PubMed - indexed for MEDLINE]
Free Article
7.

Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study.

Saif MW, Syrigos K, Penney R, Kaley K.

Anticancer Res. 2010 Jul;30(7):2905-9.

PMID:
20683031
[PubMed - indexed for MEDLINE]
8.

A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites.

Kuemmerle A, Decosterd LA, Buclin T, Liénard D, Stupp R, Chassot PG, Mosimann F, Lejeune F.

Cancer Chemother Pharmacol. 2009 Jan;63(2):331-41. doi: 10.1007/s00280-008-0743-5. Epub 2008 Jun 28.

PMID:
18587581
[PubMed - indexed for MEDLINE]
9.

Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients.

Rau KM, Li SH, Chen SM, Tang Y, Huang CH, Wu SC, Chen YY.

Jpn J Clin Oncol. 2011 Apr;41(4):455-61. doi: 10.1093/jjco/hyq232. Epub 2010 Dec 30.

PMID:
21193489
[PubMed - indexed for MEDLINE]
Free Article
10.

Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).

Roehrig S, Wein A, Albrecht H, Konturek PC, Reulbach U, Männlein G, Wolff K, Ostermeier N, Hohenberger W, Hahn EG, Boxberger F.

Med Sci Monit. 2010 Mar;16(3):CR124-131.

PMID:
20190682
[PubMed - indexed for MEDLINE]
11.

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.

Ko AH, Truong TG, Kantoff E, Jones KA, Dito E, Ong A, Tempero MA.

Cancer Chemother Pharmacol. 2012 Dec;70(6):875-81. doi: 10.1007/s00280-012-1979-7. Epub 2012 Sep 28.

PMID:
23053263
[PubMed - indexed for MEDLINE]
12.

Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer.

Micha JP, Goldstein BH, Mattison JA, Bader K, Graham C, Rettenmaier MA, Brown JV, Markman M.

Gynecol Oncol. 2005 Jan;96(1):132-5.

PMID:
15589591
[PubMed - indexed for MEDLINE]
13.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
14.

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

Abou-Alfa GK, Letourneau R, Harker G, Modiano M, Hurwitz H, Tchekmedyian NS, Feit K, Ackerman J, De Jager RL, Eckhardt SG, O'Reilly EM.

J Clin Oncol. 2006 Sep 20;24(27):4441-7.

PMID:
16983112
[PubMed - indexed for MEDLINE]
Free Article
15.

Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma.

Oettle H, Arnold D, Esser M, Huhn D, Riess H.

Anticancer Drugs. 2000 Sep;11(8):635-8.

PMID:
11081455
[PubMed - indexed for MEDLINE]
16.

Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.

Athanasiadis A, Roussos G, Papakostoulis T, Athanasiadou DC, Stathopoulos GP.

Cancer Chemother Pharmacol. 2005 Dec;56(6):653-8. Epub 2005 Jun 4.

PMID:
15937714
[PubMed - indexed for MEDLINE]
17.

Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.

Takahashi T, Higashi S, Nishiyama H, Segawa T, Nakamura E, Kinoshita H, Itoh N, Yamamoto S, Kamoto T, Habuchi T, Ogawa O.

Jpn J Clin Oncol. 2006 Feb;36(2):104-8. Epub 2006 Jan 17.

PMID:
16418182
[PubMed - indexed for MEDLINE]
Free Article
18.

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

Heinemann V, Quietzsch D, Gieseler F, Gonnermann M, Schönekäs H, Rost A, Neuhaus H, Haag C, Clemens M, Heinrich B, Vehling-Kaiser U, Fuchs M, Fleckenstein D, Gesierich W, Uthgenannt D, Einsele H, Holstege A, Hinke A, Schalhorn A, Wilkowski R.

J Clin Oncol. 2006 Aug 20;24(24):3946-52.

PMID:
16921047
[PubMed - indexed for MEDLINE]
Free Article
19.

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L.

Ai Zheng. 2007 Aug;26(8):890-4. Chinese.

PMID:
17697554
[PubMed - indexed for MEDLINE]
20.

A retrospective study of S-1 monotherapy as second-line treatment for patients with advanced biliary tract cancer.

Kobayashi S, Ueno M, Ohkawa S, Andou T, Kameda R, Yamamoto N, Morinaga S.

Jpn J Clin Oncol. 2012 Sep;42(9):800-6. doi: 10.1093/jjco/hys102. Epub 2012 Jul 23.

PMID:
22826349
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk